Stay updated on IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial

Sign up to get notified when there's something new on the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays revision v3.4.2 and the previous government funding notice has been removed. The core study details and user-facing content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T12:16:17.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the page revision to v3.4.1, while removing the previous v3.4.0 reference.
    Difference
    0.5%
    Check dated 2026-02-04T10:42:50.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page adds a glossary toggle label and minor wording changes to QC status and FEAR Act data. A revision footer indicates version 3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T06:27:56.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Footer revision updated to v3.3.4 (from v3.3.3). This is a minor metadata update with no impact on the study information or navigation.
    Difference
    0.1%
    Check dated 2026-01-14T02:54:22.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Publication added in Publications From PubMed: Barbour et al., Kidney Int. 2025 (online ahead of print), a single-arm phase 2 trial related to IgA nephropathy. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-30T20:40:15.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Consolidated location headings into a single 'Locations' section listing New South Wales, Victoria, British Columbia, and Ontario. The footer revision label updated to v3.3.3 and the 'HHS Vulnerability Disclosure' link was removed.
    Difference
    0.6%
    Check dated 2025-12-23T17:21:18.000Z thumbnail image

Stay in the know with updates to IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page.